Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Unidad de Investigacion Medica en Epidemiologia Clinica Fondo para el Fomento a la Investigacion Medica Universidad de Guadalajara |
---|---|
Information provided by: | Unidad de Investigacion Medica en Epidemiologia Clinica |
ClinicalTrials.gov Identifier: | NCT00561132 |
The purpose of this study was to evaluate if the vanadium can improve the insulin sensitivity in patients with impaired glucose tolerance. Secondary purpose of this study was to assess changes on metabolic profile, weight and blood pressure.
Condition | Intervention | Phase |
---|---|---|
Prediabetic State |
Dietary Supplement: Vanadyl sulfate Other: Magnesium oxide |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Parallel Assignment |
Official Title: | Effect of Vanadium on Insulin Sensitivity in Patients With Impaired Glucose Tolerance |
Enrollment: | 14 |
Study Start Date: | November 2003 |
Study Completion Date: | November 2004 |
Arms | Assigned Interventions |
---|---|
1: Experimental |
Dietary Supplement: Vanadyl sulfate
50 mg twice daily orally for a period of 4 weeks
|
2: Placebo Comparator |
Other: Magnesium oxide
Validation of similar appearance and weight to the intervention component orally 1 unit (<50 mg) twice daily for a period of 4 weeks
|
Ages Eligible for Study: | 40 Years to 50 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Mexico, Jalisco | |
Unidad de Investigacion Medica en Epidemiologia Clinica, Hospital de Especialidades, UMAE, Centro Medico Nacional de Occidente | |
Guadalajara, Jalisco, Mexico, 44320 |
Principal Investigator: | Omar Jacques-Camarena, MD, MSc | Unidad de Investigacion Medica en Epidemiologia Clinica |
Principal Investigator: | Manuel González-Ortiz, MD, MSc, PhD | Unidad de Investigacion Medica en Epidemiologia Clinica |
Study Director: | Esperanza Martínez-Abundis, MD, MSc, PhD | Unidad de Investigacion Medica en Epidemiologia Clinica |
Study ID Numbers: | 2002/252/129, 173/03/13, FP-2003/073 |
Study First Received: | November 19, 2007 |
Last Updated: | November 19, 2007 |
ClinicalTrials.gov Identifier: | NCT00561132 |
Health Authority: | Mexico: Ministry of Health |
vanadium insulin sensitivity impaired glucose tolerance triglycerides |
Vanadium Metabolic Diseases Magnesium Oxide Glucose Intolerance Prediabetic State Diabetes Mellitus Endocrine System Diseases |
Insulin Hyperglycemia Vanadyl sulfate Endocrinopathy Glucose Metabolism Disorders Metabolic disorder |
Hypoglycemic Agents Molecular Mechanisms of Pharmacological Action Growth Substances Physiological Effects of Drugs |
Trace Elements Antacids Micronutrients Pharmacologic Actions |